CN
Coherence Neuro
United States · Healthtech · Biotech
Investigational implants and bioelectronic systems for monitoring and treating cancer.
Product
Coherence Neuro develops implantable devices that record electrical activity and deliver stimulation, with an initial focus on brain cancer. Its research combines neurotechnology, cancer biology and machine learning to investigate how electrical signals might help clinicians monitor disease.
The company’s proposed SOMA system combines a wireless implant, an over-ear power and memory unit, and a companion app. Founders Ben Woodington and Elise Jenkins lead a team working across San Francisco and Cambridge, UK. Its systems remain under development, and the company is progressing clinical studies.
Funding history
1 round · 1 with disclosed amounts| Announced | Round | Amount | Investors |
|---|---|---|---|
| Series A | $45M | Founders Fund — LeadOpenAI Startup Fund — Lead8VC — ParticipantAhren Innovation Capital — ParticipantArtesian — ParticipantBlackbird Ventures — ParticipantDivergent Capital — ParticipantLux Capital — ParticipantOlive Capital — ParticipantPossible Ventures — ParticipantTimeless Partners — ParticipantTopology Ventures — ParticipantXEIA Venture Partners — ParticipantXtal — Participant |